Answers are grounded in this paper and cite their sources.
Research reports synthesis of molybdenum nitrido NHC complexes, showing their activity in cross-metathesis reactions.
The synthesis of molybdenum(VI) nitrido N ‐heterocyclic carbene (NHC) complexes bearing alkoxide and siloxide ligands, respectively, is reported. The molybdenum nitrido trisalkoxide precursor Mo(≡N)(OC(CF 3 ) 2 (CH 3 )) 3 is reacted with the NHCs 1,3‐diisopropylimidazol‐2‐ylidene (IiPr), 1,3‐dimethylimidazol‐2‐ylidene (IMe), and 1,3‐dicyclohexylimidazol‐2‐ylidene (ICy), respectively, to yield the corresponding molybdenum nitrido trisalkoxide NHC complexes. Further salt metathesis allows to replace the alkoxide ligands by the thermally more robust siloxide ligands. In case an asymmetric NHC, i.e., 1‐butyl‐3‐methylimidazol‐2‐ylidene, is reacted with the trisalkoxide precursor, a mixture of two isomers of the corresponding product is observed; these two isomers interconvert to some extent at elevated temperature. Selected complexes are subjected to single‐crystal X‐ray analysis. The molybdenum nitrido NHC complexes show moderate activity in alkyne cross‐metathesis.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: